Cardiovascular autonomic imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse

Cellular Physiology and Biochemistry

Volumn 29, Issue 5-6, 2012, Pages 635-646

  Vasquez, Elisardo C ^a,b   Peotta, Veronica A ^c   Meyrelles, Silvana S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Atherosclerosis; Autonomic nervous system; Baroreflex function; Hypercholesterolemia; Mouse

Indexed keywords

APOLIPOPROTEIN E; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADRENERGIC SYSTEM; AGING; ATHEROGENIC DIET; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CHOLINERGIC SYSTEM; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANIMALIA;

EID: 84861393523     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000277623     Document Type: Review

References (70)

1. Borst O, Ochmann C, Schönberger T, Jacoby C, Stellos K, Seizer P, Flögel U, Lang F, Gawaz M: Methods employed for induction and analysis of experimental myocardial infarction in mice. Cell Physiol Biochem 2011;28:1-12.
2. Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS: Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis 2010;9:87.
3. Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 2005;46:932-936.
4. Cola MS, Gava AL, Meyrelles SS, Vasquez EC: Endothelial dysfunction of resistance vessels in female apolipoprotein Edeficient mice. Lipids Health Dis 2010;9:51.
5. Balarini CM, Oliveira MZ, Pereira TM, Silva NF, Vasquez EC, Meyrelles SS, Gava AL: Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis 2011;10:220.
6. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-471.
7. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
8. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992;89:4471-4475.
9. Zhang SH, Reddick RL, Burkey B, Maeda N: Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994;94:937-945. (Pubitemid 24286433)
10. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ: Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1996;93:10022-10027.
11. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM: Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 1997;17:2333-2340. (Pubitemid 28015965)
12. (A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. Cardiovasc Res 2002;53:487-495. (Pubitemid 34117700)
13. Surra JC, Guillén N, Arbonés-Mainar JM, Barranquero C, Navarro MA, Arnal C, Orman I, Segovia JC, Osada J: Sex as a profound modifier of atherosclerotic lesion development in apolipoprotein Edeficient mice with different genetic backgrounds. J Atheroscler Thromb 2010;17:712-721.
14. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-140.
15. Jiang F, Gibson AP, Dusting GJ: Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice. Eur J Pharmacol 2001;424:141-149. (Pubitemid 32718618)
16. Yamashita T, Kawashima S, Ozaki M, Namiki M, Shinohara M, Inoue N, Hirata K, Umetani K, Yokoyama M: In vivo angiographic detection of vascular lesions in apolipoprotein E-knockout mice using a synchrotron radiation microangiography system. Circ J 2002;66:1057-1059. (Pubitemid 35416345)
17. Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC: Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis 2011;10:211.
18. Wassmann S, Czech T, van Eickels M, Fleming I, Böhm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004;110:3062-3067. (Pubitemid 39491999)
19. Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res 2007;38:816-821. (Pubitemid 47513267)
20. Stapleton PA, Goodwill AG, James ME, Frisbee JC: Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia. Am J Physiol Regul Integr Comp Physiol 2007;293:R1110-1119. (Pubitemid 47358931)
21. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H: Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 1999;19:2762-2768. (Pubitemid 29536055)
22. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Münter K, Lüscher TF: Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 1998;95:14367-14372.
23. Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U: Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008;117:2377-2387. (Pubitemid 351653554)
24. -/- mice in vivo. Circulation 2003;107:2480-2486. (Pubitemid 36605232)
25. Hans CP, Feng Y, Naura AS, Zerfaoui M, Rezk BM, Xia H, Kaye AD, Matrougui K, Lazartigues E, Boulares AH: Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress. PLoS One 2009;4:e7430.
26. Agarwal R: Regulation of circadian blood pressure: from mice to astronauts. Curr Opin Nephrol Hypertens 2010;19:51-58.
27. Abboud FM: The Walter B: Cannon Memorial Award Lecture, 2009. Physiology in perspective: The wisdom of the body. In search of autonomic balance: the good, the bad, and the ugly. Am J Physiol Regul Integr Comp Physiol 2010;298:R1449-1467.
28. Chapleau MW, Sabharwal R: Methods of assessing vagus nerve activity and reflexes. Heart Fail Rev 2011;16:109-127.
29. Peotta VA, Gava AL, Vasquez EC, Meyrelles SS: Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Can J Physiol Pharmacol 2007;85:761-766. (Pubitemid 350144735)
30. Janssen BJ, Smits JF: Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol 2002;282:R1545-1564. (Pubitemid 34664479)
31. Swoap SJ, Li C, Wess J, Parsons AD, Williams TD, Overton JM: Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality. Am J Physiol Heart Circ Physiol 2008;294:H1581-1588. (Pubitemid 351490587)
32. Young CN, Davisson RL: In vivo assessment of neurocardiovascular regulation in the mouse: principles, progress, and prospects. Am J Physiol Heart Circ Physiol 2011;301:H654-662.
33. Evangelho JS, Casali KR, Campos C, De Angelis K, Veiga A B G, Rigatto K: Hypercholesterolemia magnitude increases sympathetic modulation and coagulation in LDLr knockout mice. Auton Neurosci 2011;159:98-103.
34. Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, Berger RD: Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest 1998;102:1279-1285. (Pubitemid 28467555)
35. Chapleau MW, Li Z, Meyrelles SS, Ma X, Abboud FM: Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci 2001;940:1-19. (Pubitemid 32623379)
36. Ma X, Abboud FM, Chapleau MW: Neurocardiovascular regulation in mice: experimental approaches and novel findings. Clin Exp Pharmacol Physiol 2003;30:885-893. (Pubitemid 37506157)
37. Vasquez EC, Meyrelles SS, Mauad H, Cabral AM: Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex. Braz J Med Biol Res 1997;30:521-532. (Pubitemid 27195719)
38. Braga VA, Burmeister MA, Sharma RV, Davisson RL: Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry. Am J Physiol Regul Integr Comp Physiol 2008;295:R1168-1174.
39. Peotta VA, Vasquez EC, Meyrelles SS: Cardiovascular neural reflexes in LNAME-induced hypertension in mice. Hypertension 2001;38:555-559.
40. Gava AL, Peotta VA, Cabral AM, Meyrelles SS, Vasquez EC: Decreased baroreflex sensitivity in isoproterenoltreated mice with cardiac hypertrophy. Auton Neurosci 2004;114:47-54. (Pubitemid 39157348)
41. Gava AL, Peotta VA, Cabral AM, Vasquez EC, Meyrelles SS: Overexpression of eNOS prevents the development of renovascular hypertension in mice. Can J Physiol Pharmacol 2008;86:458-464. (Pubitemid 351948685)
42. Meyrelles SS, Mao HZ, Heistad DD, Chapleau MW: Gene transfer to carotid sinus in vivo: a novel approach to investigation of baroreceptors. Hypertension 1997;30:708-713. (Pubitemid 27444260)
43. Meyrelles SS, Sharma RV, Whiteis CA, Davidson BL, Chapleau MW: Adenovirus-mediated gene transfer to cultured nodose sensory neurons. Brain Res Mol Brain Res 1997;51:33-41. (Pubitemid 27504029)
44. Meyrelles SS, Chapleau MW: Analysis of carotid baroreflex using sequential carotid occlusion and gene transfer in mice. Hypertension 1999;33:A1085.
45. Oosting J, Struijker-Boudier HA, Janssen BJ: Validation of a continuous baroreceptor reflex sensitivity index calculated from spontaneous fluctuations of blood pressure and pulse interval in rats. J Hypertens 1997;15:391-399. (Pubitemid 27187142)
46. Janssen BJ, Leenders PJ, Smits JF: Shortterm and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol 2000;278:R215-225. (Pubitemid 30182692)
47. Butz GM, Davisson RL: Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 2001;5:89-97. (Pubitemid 33675206)
48. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CI: Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol 2000;279:H733-740.
49. Just A, Faulhaber J, Ehmke H: Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 2000;279:R2214-2221.
50. Ma XY, Abboud FM, Chapleau MW: Altered baroreflex control of renal sympathetic nerve activity in normotensive apo-E deficient atherosclerotic mice. The Physiologist 2000;43:A275.
51. Meyrelles SS, Chapleau MW: Impaired carotid occlusion reflex in apoE deficient mice and its reversal by gene transfer to carotid sinus. J Hypertens 2000;18(Suppl. 4):S202.
52. Sun W, Abboud FM, Chapleau MW: Altered baro-and chemoreflex sensitivity revealed by carotid artery occlusion reflex in apo-E knockout mice. FASEB J 2001;15:A1146.
53. Ma X, Zhang HJ, Whiteis CA, Tian X, Davisson RL, Kregel KC, Abboud FM, Chapleau MW: NAD (P) H oxidaseinduced oxidative stress in sympathetic ganglia of apolipoprotein E deficient mice. Auton Neurosci 2006;126-127:285-291. (Pubitemid 43816909)
54. Sun W, Abboud FM, Chapleau MW: Impaired carotid occlusion reflex in Apo-E deficient mice is normalized with age and increasing severity of atherosclerotic lesions. The Physiologist 2000;43:A276.
55. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM: Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;106:927-932. (Pubitemid 34925325)
56. Santos CM, Moreira ED, Krieger EM, Michelini LC: Chronic AT1 receptor blockade alters aortic nerve activity in hypertension. Hypertension 1998;31:973-977. (Pubitemid 28185576)
57. Arakawa K, Urata H: Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension 2000;36:638-641.
58. 1A receptor. Circulation 2004;110:3849-3857. (Pubitemid 40023984)
59. + mice with hypercholesterolemia, hypertension, and decreased baroreflex sensitivity spontaneously develop heart failure with age. FASEB J 2007;21:753.14.
60. Lu Y, Ma X, Sabharwal R, Snitsarev V, Morgan D, Rahmouni K, Drummond HA, Whiteis CA, Costa V, Price M, Benson C, Welsh MJ, Chapleau MW, Abboud FM: The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation. Neuron 2009;64:885-897.
61. Sabharwal R, Chapleau MW, Price MP, Welsh MJ, Abboud FM: Molecular mechanisms of baro-and chemoreceptor activation: evidence that ASIC1 and ASIC3 contribute to chemoreceptor activation (Abstract). Circulation 2005;112:156.
62. -/- mice: a genetic model of impaired baroreceptor activation and oxidative stress-dependent neurogenic hypertension (Abstract). Hypertension 2006;48:e31.
63. Hofker MH, van Vlijmen B J M, Havekes LM: Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 1998;137:1-11. (Pubitemid 28175371)
64. Jawien J, Nastalek P, Korbut R: Mouse models of experimental atherosclerosis. J Physiol Pharmacol 2004;55:503-517. (Pubitemid 39318844)
65. Meir KS, Leitersdorf E: Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004;24:1006-1014. (Pubitemid 38737824)
66. Wang Y-X: Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice. Neurobiol Aging 2005;26:309-316. (Pubitemid 40082713)
67. Lu H, Cassis LA, Daugherty A: Atherosclerosis and arterial blood pressure in mice. Curr Drug Targets 2007;8:1181-1189. (Pubitemid 350238919)
68. Vasquez EC, Peotta VA, Gava AG, Pereira T M C, Meyrelles SS: Cardiac and vascular phenotypes in the apolipoprotein Edeficient mouse. J Biomed Sci 2012;19:22.
69. Imaizumi K: Diet and atherosclerosis in apolipoprotein E-deficient mice. Biosci Biotechnol Biochem 2011;75:1023-1035.
70. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, Princen HM, Kooistra T: Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007;27:1706-1721. (Pubitemid 47207165)